Research in social & administrative pharmacy : RSAP
-
Res Social Adm Pharm · Dec 2010
Exploring successful community pharmacist-physician collaborative working relationships using mixed methods.
Collaborative working relationships (CWRs) between community pharmacists and physicians may foster the provision of medication therapy management services, disease state management, and other patient care activities; however, pharmacists have expressed difficulty in developing such relationships. Additional work is needed to understand the specific pharmacist-physician exchanges that effectively contribute to the development of CWR. Data from successful pairs of community pharmacists and physicians may provide further insights into these exchange variables and expand research on models of professional collaboration. ⋯ The findings support and extend the literature on pharmacist-physician CWRs by examining the exchange domains of relationship initiation, trustworthiness, and role specification qualitatively and quantitatively among pairs of practitioners. Relationships appeared to develop in a manner consistent with a published model for CWRs, including the pharmacist as relationship initiator, the importance of communication during early stages of the relationship, and an emphasis on high-quality pharmacist contributions.
-
Migraine is a common, disabling, and underdiagnosed condition. Pharmacists are in an excellent position to help improve migraineur outcomes. The Pharmacists Care of Migraineurs Scale (PCMS) may be useful for documenting migraineur care and in the design and targeting of interventions aimed at improving care. ⋯ Self-assessed knowledge of migraine, perceived lack of difficulty, and caring ability are important determinants in the level of care provided to migraineurs by pharmacists. Future study should further delineate the role of the pharmacy's work environment and pharmacists' training needs in elevating levels of care. Comprehensive continuing education programs on migraine management would appear advisable.
-
Res Social Adm Pharm · Sep 2010
Problem prescriptions in Sweden necessitating contact with the prescriber before dispensing.
Pharmacists have an important role in detecting, preventing, and solving prescription problems, which if left unresolved, may pose a risk of harming the patient. ⋯ Computerized physician order entry (CPOE) and electronically transmitted prescriptions (ETP) can not only reduce the total rate of prescription problems, but also introduce new clinically important errors that may compromise patient safety and medication outcome. The prescription problem rates in the present study differed across prescriber groups and patient age and gender, and the inverse correlation to pharmacy size indicates that all problems are not revealed and corrected and may thus reach the patient. CPOE and ETP have been used extensively in Sweden for the past decade, but the present study indicates that there is still a potential and need for improvement for the vision of "no prescribing errors/problems will reach the patient" to come true.
-
Res Social Adm Pharm · Jun 2010
Development of a scale to measure pharmacists' self-efficacy in performing medication therapy management services.
Measuring community pharmacists' self-efficacy in performing medication therapy management (MTM) services can be useful for tailoring interventions and predicting participation. ⋯ Constructs for measuring self-efficacy were identified that may aid in future research predicting whether pharmacists engage in and persist in providing MTM services.
-
Res Social Adm Pharm · Jun 2010
Comparative StudyImpact of cost sharing on prescription drugs used by Medicare beneficiaries.
Incentive-based prescription drug cost sharing can encourage seniors to use generic medications. Little information exists about prescription drug cost sharing and generic use in employer-sponsored plans after the implementation of Medicare Part D. ⋯ Medicare beneficiaries in Part D had higher cost sharing amounts than those with employer coverage, but higher cost sharing was not significantly linked to lower prescription use. Generic use for Part D beneficiaries was higher than that for beneficiaries with employer coverage but the same as that for beneficiaries without drug coverage.